甲抗素缺乏是心血管疾病风险因素吗?
María Torres-Durán1, Esmeralda García-Rodríguez2, Laura Villar-Aguilar2
1Centro de Investigación Biomédica en Red, CIBERES ISCIII, Madrid, Spain.
ERJ open research
|October 29, 2025
概括
阿尔法-1抗素缺乏可能是一个独立的心血管风险因素. 需要提高临床意识和进一步的研究来理解这种潜在的联系.
科学领域:
- 心血管医学 心血管医学
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔法-1抗素缺乏症 (AATD) 是一种遗传性疾病,主要影响肺和肝脏.
- 新出现的证据表明,AATD与心血管疾病 (CVD) 之间存在潜在的联系.
研究的目的:
- 调查是否α-1抗素缺乏是心血管疾病的独立风险因素.
- 突出需要在心血管风险评估中提高对AATD的临床警.
主要方法:
- 审查现有的文献和临床数据.
- 对患有和没有AATD的患者心血管结果的分析.
主要成果:
- 初步发现表明,AATD可能会独立地导致心血管风险.
- 需要进一步的研究来证实这些关联并阐明机制.
结论:
- 阿尔法-1抗素缺乏需要考虑作为潜在的独立心血管风险因素.
- 提高临床意识和专门的研究对于管理与AATD相关的心血管风险至关重要.
相关概念视频
Coronary Artery Disease I: Introduction
869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
Psychoneuroimmunology: Cardiovascular Disease
382
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
382
Coronary Artery Disease IV: Preventive Measures
580
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
580
Atherosclerosis I: Introduction
890
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
890
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531

